Next-generation obesity drug shows promise for diabetes management and significant weight loss

An experimental Eli Lilly drug, retatrutide, has demonstrated substantial weight loss and improved blood-sugar control in people with type 2 diabetes, signalling a potential breakthrough in metabolic health treatments. An experimental Eli Lilly obesity drug has helped people with type…















